Skip to main content

Icon Legend
ICONS KEY
CE Credit Available
CE Credit Available
Pharmacology Credit Available
Pharmacology Credit Available
Poster Activities
Poster Activities

Full Schedule

Full Schedule

  • Friday, November 15, 2024
  • 7:00 AM – 8:00 AM CT
    Exhibit Hall Open & Continental Breakfast
  • 7:15 AM – 8:15 AM CT
    Breakfast Activity/Non-CE Accredited Satellite Symposium: CARVYKTI® Product Summary for Patient Care Teams
    Johnson & Johnson
  • 7:15 AM – 8:15 AM CT
    Breakfast Activity/Non-CE Accredited Satellite Symposium: Supporting Patients With HR+/HER2- mBC Throughout Their Treatment Journey
    Pfizer, Inc.
  • 7:15 AM – 8:15 AM CT
    Breakfast Activity/Non-CE Accredited Satellite Symposium: Treatment Option for Patients with Unresectable or Metastatic Melanoma​
    Bristol Myers Squibb
  • 7:30 AM – 5:30 PM CT
    Registration
  • 8:20 AM – 8:30 AM CT
    Welcome & Opening Remarks
  • 8:30 AM – 9:45 AM CT
    Opening Panel Discussion: Understanding the Benefits and Pitfalls of Artificial Intelligence in Oncology
  • 9:45 AM – 4:30 PM CT
    Braindate
  • 9:50 AM – 10:50 AM CT
    Complicating “Factors”: When Malignancy and Non-Malignant Hematology Collide
  • 9:50 AM – 10:50 AM CT
    Fast Tracking Recovery: Enhancing Surgical Outcomes in Oncology
  • 9:50 AM – 10:50 AM CT
    New Drug Updates in Solid Tumors
  • 10:50 AM – 11:20 AM CT
    APSHO Meet & Greet: Awards & Recognition Committee
  • 10:50 AM – 11:50 AM CT
    Exhibit Hall Open & Refreshment Break
  • 11:05 AM – 11:35 AM CT
    Exhibit Hall Presentation: Clinical Considerations for the Treatment of mTNBC and HR+/HER2- mBC with an ADC
    Gilead
  • 11:05 AM – 11:35 AM CT
    Exhibit Hall Presentation: Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor.
    Lilly
  • 11:05 AM – 11:50 AM CT
    Exhibit Hall Presentation: Practical Management of AML with a BCL-2 Inhibitor
    AbbVie
  • 11:20 AM – 11:50 AM CT
    APSHO Meet & Greet: Communications Committee
  • 11:50 AM – 12:35 PM CT
    Cancer Complexities: Balancing Your Patient’s Comorbidities With Their Treatments
  • 11:50 AM – 12:35 PM CT
    Updates in HR-Positive HER2-Negative Metastatic Breast Cancer for the Advanced Practitioner
  • 12:35 PM – 2:00 PM CT
    Exhibit Hall Open & Lunch
  • 12:35 PM – 2:00 PM CT
    Lunch Activity/Non-CE Accredited Satellite Symposium
  • 1:15 PM – 1:45 PM CT
    APSHO Meet & Greet: Diversity Equity & Inclusion (DEI) Committee
  • 2:00 PM – 3:00 PM CT
    Keynote Address
  • 3:00 PM – 3:30 PM CT
    APSHO Meet & Greet: Board of Directors
  • 3:00 PM – 3:45 PM CT
    Moderated Posters: Clinical Posters, Industry Encore Posters, and APSHO Patient Advocacy Posters
  • 3:00 PM – 4:00 PM CT
    Exhibit Hall Open & Refreshment Break
  • 3:15 PM – 3:45 PM CT
    Exhibit Hall Presentation Theater
  • 3:30 PM – 4:00 PM CT
    APSHO Meet & Greet: Membership Committee
  • 3:45 PM – 4:15 PM CT
    Updates in the Surgical Management of Small Renal Tumors
  • 3:45 PM – 4:45 PM CT
    Successful Management of Patients Receiving Bispecific Antibodies for Hematologic Malignancies
  • 3:45 PM – 5:00 PM CT
    Oral Poster Presentations (Part 1)
  • 4:15 PM – 4:45 PM CT
    Updates in the Surgical Management of Small Lung Tumors
  • 5:00 PM – 5:45 PM CT

    Independent CE-Accredited Satellite Symposium

    Treatment Advances For Advanced Prostate Cancer: Guideline Updates and Newer Therapies
  • 5:45 PM – 6:30 PM CT

    Independent CE-Accredited Satellite Symposium

    Opportunities for Improved Outcomes: The Role of Targeted Therapies in Metastatic Urothelial Carcinoma
  • 6:30 PM – 8:30 PM CT

    Independent CE-Accredited Dinner Satellite Symposium

    Optimizing the Patient Journey in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Evolving Guidelines, Emerging Options, and Multidisciplinary Management Strategies